Search PubMed⌕ Search

Biomedical subjects

G Lagrue

Publications and source records attributed to G Lagrue.

At least 289 records · Page 16Linked to original sources
PubMed1975

[Study of several parameters of hemostasis in Masugi's rabbit nephritis].

During experimental Masugi nephritis in the rabbit, were demonstrated various disturbances in hemostasis: a) during the initial stage: immediate, severe and transient fall in the platelet count without any change in Factor V;b)during the secondary stage, from the 7th to the 8th day onwards, increase in platelets and fibrinogen, in relation with the intensity of the nephrotic syndrome; c) in parallel, appearance of urinary fibrinogen split products in relation to the intensity of the glomerular lesions, evidence for the presence of intraglomerular fibrin. These facts confirm the role played by platelets in coagulation phenomena secondary to the immune reaction. They indicate, furthermore, the existence of hemostasis disorders during the nephrotic syndrome.

Animals↗
PubMed1975

[ Products of fibrin degradation in the urine during experimental and human glomerulonephritis].

Intravascular coagulation localized in glomeruli is of pathologic importance in human and experimental GN. The measure of fibrinogen related antigen (FRA) in serum and urine after concentration (Merskey's technique) was used to detect and estimate this phenomenon. In Rabbit Masugi GN, FRA were detected in urine 5 to 20 mg/24 h, in close correlation with the amount of proteinuria, the intesity of histological changes and the presence of fibrin deposits in glomeruli. In human GN, urine FRA were detected in many cases (0,5-10 mg/24 h) in correlation with the histological type of lesions (FRA + in primary or secondary proliferative GN) and with the evolutivity of disease (FRA + in cases with rapidly progressive kidney function deficiency). Urine FRA are also in correlation with intraglomerular fibrin deposits : this suggests that urine FRA originate from lysis of fibrin deposited within glomeruli. So urine FRA appears to be an indicator of type and severity of GN and probably of therapeutic measures, indicating anticoagulant and/or antithrombic therapy : the variations of urine FRA during treatment is of value to assess the effects of these drugs and to establish the prognosis of the disease.

Animals↗
PubMed1975

Lymphokine 'skin reactive factor' (SRF) and the nephrotic syndrome.

Lymphocytes from N.S. patients, in culture and stimulated by PHA or Con A, release a lymphokine which increases vascular permeability; this factor is not present in normal subject and in control supernatants. Pharmacological and biological properties of this factor are similar to the guinea pig S.R.F. (PICK, TURK, MAILLARD). Modifications observed with meclofenamate, DTTC and addition of N.H.S. suggest that it could be an activator of the kinin system. Physicochemical studies show that it is a protein migrating as albumin. We have also recently demonstrated (unpublished data) the relationship of this factor with proteinuria: injections of active supernatants in rats renal artery is immediately followed by increase in proteinuria from 0,8 mg/h to 3,5 mg/h. Up to date, lymphokines have been studied in animals but seldom in human. Our results show that in human, variations in lymphokine production may be present. Pathogenic implications are now under study.

Animals↗